目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Meningitis Diagnostic Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis

Chapter 4. Meningitis Diagnostic Testing Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Latex Agglutination Tests
4.4.1. Latex Agglutination Tests Market, 2018 - 2030 (USD Million)
4.5. Lateral Flow Assay
4.5.1. Lateral Flow Assay Market, 2018 - 2030 (USD Million)
4.6. PCR Assay
4.6.1. PCR Assay Market, 2018 - 2030 (USD Million)
4.7. ELISA Tests
4.7.1. ELISA Tests Market, 2018 - 2030 (USD Million)
4.8. Culture Test
4.8.1. Culture Test Market, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Meningitis Diagnostic Testing Market: End Use Business Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
5.5. Diagnostic Centers
5.5.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Meningitis Diagnostic Testing Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Canada Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Meningitis Diagnostic Testing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Meningitis Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Thermo Fisher Scientific Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Type Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Bio-Rad Laboratories, Inc
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Type Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Abbott.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Type Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. ELITechGroup
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Type Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Seegene Inc.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Type Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. DiaSorin S.p.A.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Type Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. CERTEST BIOTEC.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Type Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. IMMY.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Type Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Uniogen Oy
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Type Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. BIOMÉRIEUX
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Type Benchmarking
7.5.10.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global meningitis diagnostic testing market, by region, 2018 - 2030 (USD Million)
Table 4 Global meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 5 Global meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 6 North America meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
Table 7 North America meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 8 North America meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 9 U.S meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 10 U.S meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 12 Canada meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 13 Mexico meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 14 Mexico meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 15 Mexico meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 16 Europe meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
Table 17 Europe meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 18 Europe meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 19 UK meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 20 UK meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 21 Germany meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 22 Germany meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 23 France meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 24 France meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 25 Italy meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 26 Italy meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 27 Spain meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 28 Spain meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 29 Norway meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 30 Norway meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 31 Denmark meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 33 Sweden meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 34 Sweden meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 35 Asia Pacific meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
Table 36 Asia Pacific meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 37 Asia Pacific meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 38 Japan meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 39 Japan meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 40 China meningitis diagnostic testing market, by type, 2018-2030 (USD Million)
Table 41 China meningitis diagnostic testing market, by end use, 2018-2030 (USD Million)
Table 42 India meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 43 India meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 44 Australia meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 45 Australia meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 46 South Korea meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 47 South Korea meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 48 Thailand meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 49 Thailand meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 50 Latin America meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
Table 51 Latin America meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 52 Latin America meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 53 Brazil meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 54 Brazil meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 55 Argentina meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 56 Argentina meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa meningitis diagnostic testing market, by country, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 59 Middle East & Africa meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 60 South Africa meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 61 South Africa meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 63 Saudi Arabia meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 64 UAE meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 65 UAE meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)
Table 66 Kuwait meningitis diagnostic testing market, by type, 2018 - 2030 (USD Million)
Table 67 Kuwait meningitis diagnostic testing market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Meningitis diagnostic testing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type outlook (USD Million)
Fig. 10 End use outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Meningitis diagnostic testing market dynamics
Fig. 13 Meningitis diagnostic testing market: Porter’s five forces analysis
Fig. 14 Meningitis diagnostic testing market: PESTLE analysis
Fig. 15 Meningitis diagnostic testing market: Type segment dashboard
Fig. 16 Meningitis diagnostic testing market: Type market share analysis, 2024 & 2030
Fig. 17 Latex agglutination tests market, 2018 - 2030 (USD Million)
Fig. 18 Lateral flow assay market, 2018 - 2030 (USD Million)
Fig. 19 PCR assay market, 2018 - 2030 (USD Million)
Fig. 20 ELISA tests market, 2018 - 2030 (USD Million)
Fig. 21 Culture test market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Meningitis diagnostic testing market: End use segment dashboard
Fig. 24 Meningitis diagnostic testing market: End use market share analysis, 2024 & 2030
Fig. 25 Hospitals market, 2018 - 2030 (USD Million)
Fig. 26 Diagnostic centers market, 2018 - 2030 (USD Million)
Fig. 27 Others market, 2018 - 2030 (USD Million)
Fig. 28 Meningitis diagnostic testing market revenue, by region
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 North America meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 31 U.S. country dynamics
Fig. 32 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 33 Canada country dynamics
Fig. 34 Canada meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 35 Mexico country dynamics
Fig. 36 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 37 Europe meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 38 UK country dynamics
Fig. 39 UK meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 40 Germany country dynamics
Fig. 41 Germany meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 42 France country dynamics
Fig. 43 France meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 44 Italy country dynamics
Fig. 45 Italy meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 46 Spain country dynamics
Fig. 47 Spain meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 48 Norway country dynamics
Fig. 49 Norway meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 50 Denmark country dynamics
Fig. 51 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD Million
Fig. 52 Sweden country dynamics
Fig. 53 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 55 Japan country dynamics
Fig. 56 Japan meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 57 China country dynamics
Fig. 58 China meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 59 India country dynamics
Fig. 60 India meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 61 South Korea country dynamics
Fig. 62 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 63 Australia country dynamics
Fig. 64 Australia meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 65 Thailand country dynamics
Fig. 66 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 67 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 68 Brazil country dynamics
Fig. 69 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 70 Argentina country dynamics
Fig. 71 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 72 MEA meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 73 South Africa country dynamics
Fig. 74 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia country dynamics
Fig. 76 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 77 UAE country dynamics
Fig. 78 UAE meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 79 Kuwait country dynamics
Fig. 80 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 81 Company categorization
Fig. 82 Company market position analysis
Fig. 83 Strategic framework